Reportstack is one of the largest online libraries of market research publications. We are the fastest growing and most preferred provider of business intelligence in the market today. We partner with the world's top publishers and research houses to bring to you expert analysis, accurate data and market information along with the best customer support and user experience. For more details, please visit www.reportstack.com

Thursday, 13 April 2017

Global Chlortetracycline Hydrochloride Market Outlook 2017-2022 is a new market research publication announced by Reportstack. Chlortetracycline is a tetracycline antibiotic, the first tetracycline to be identified. It was discovered in 1945 by Benjamin Minge Duggar working at Lederle Laboratories under the supervision of Yellapragada Subbarow. Duggar identified the antibiotic as the product of an actinomycete he cultured from a soil sample collected from Sanborn Field at the University of Missouri. The organism was named Streptomyces aureofaciens and the isolated drug, Aureomycin, because of their golden color. Chlortetracycline hydrochloride ointment is indicated in the topical treatment of minor skin infections caused by streptococci, staphylococci, and other susceptible organisms.

This report provides detailed analysis of worldwide markets for Chlortetracycline Hydrochloride from 2011-2016, and provides extensive market forecasts (2016-2021) by region/country and subsectors. It covers the volumes, prices, historical growth and future perspectives in the Chlortetracycline Hydrochloride market and further lays out an analysis of the factors influencing the supply/demand for Chlortetracycline Hydrochloride, and the opportunities/challenges faced by industry participants. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies.

The report has been prepared based on the synthesis, analysis, and interpretation of information about the global Chlortetracycline Hydrochloride market collected from specialized sources. The report covers key technological developments in the recent times and profiles leading players in the market and analyzes their key strategies. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. The major players in the global Chlortetracycline Hydrochloride market are Fujian Fukang Pharmaceutical (China), Pucheng Chia Tai Biochemistry (China), etc.

The report provides separate comprehensive analytics for the North America, Europe, Asia-Pacific, Middle East and Africa and Rest of World. In this sector, global competitive landscape and supply/demand pattern of Chlortetracycline Hydrochloride industry has been provided.